Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ... Progress in neurobiology 132, 96-168, 2015 | 491 | 2015 |
Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens P De Deurwaerdère, S Navailles, KA Berg, WP Clarke, U Spampinato Journal of Neuroscience 24 (13), 3235-3241, 2004 | 381 | 2004 |
Noradrenaline and Parkinson's disease C Delaville, P Deurwaerdère, A Benazzouz Frontiers in systems neuroscience 5, 31, 2011 | 266 | 2011 |
Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study G Di Giovanni, P De Deurwaerdère, M Di Mascio, V Di Matteo, E Esposito, ... Neuroscience 91 (2), 587-597, 1999 | 261 | 1999 |
5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum G Porras, V Di Matteo, C Fracasso, G Lucas, P De Deurwaerdère, ... Neuropsychopharmacology 26 (3), 311-324, 2002 | 260 | 2002 |
Anxiety-like behavior in crayfish is controlled by serotonin P Fossat, J Bacqué-Cazenave, P De Deurwaerdère, JP Delbecque, ... Science 344 (6189), 1293-1297, 2014 | 248 | 2014 |
Serotonin in animal cognition and behavior J Bacqué-Cazenave, R Bharatiya, G Barrière, JP Delbecque, ... International journal of molecular sciences 21 (5), 1649, 2020 | 221 | 2020 |
Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease S Navailles, B Bioulac, C Gross, P De Deurwaerdère Neurobiology of disease 38 (1), 136-143, 2010 | 215 | 2010 |
Role of Serotonin2A and Serotonin2B/2C Receptor Subtypes in the Control of Accumbal and Striatal Dopamine Release Elicited In Vivo by Dorsal Raphe Nucleus … P De Deurwaerdère, U Spampinato Journal of neurochemistry 73 (3), 1033-1042, 1999 | 205 | 1999 |
Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications P De Deurwaerdère, G Di Giovanni Progress in neurobiology 151, 175-236, 2017 | 175 | 2017 |
Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors P De Deurwaerdere, L Stinus, U Spampinato Journal of Neuroscience 18 (16), 6528-6538, 1998 | 172 | 1998 |
Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat N Bonhomme, P De Deurwaerdere, M Le Moal, U Spampinato Neuropharmacology 34 (3), 269-279, 1995 | 159 | 1995 |
Presynaptic control of serotonin on striatal dopamine function S Navailles, P De Deurwaerdère Psychopharmacology 213, 213-242, 2011 | 130 | 2011 |
8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release G Lucas, N Bonhomme, PD Deurwaerdère, ML Moal, U Spampinato Psychopharmacology 131, 57-63, 1997 | 127 | 1997 |
High-frequency stimulation of the subthalamic nucleus and L-3, 4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat … S Navailles, A Benazzouz, B Bioulac, C Gross, P De Deurwaerdere Journal of Neuroscience 30 (6), 2356-2364, 2010 | 121 | 2010 |
Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry P De Deurwaerdère, G Di Giovanni, MJ Millan Progress in neurobiology 151, 57-100, 2017 | 120 | 2017 |
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders G Di Giovanni, P De Deurwaerdère Pharmacology & therapeutics 157, 125-162, 2016 | 118 | 2016 |
Emerging dysfunctions consequent to combined monoaminergic depletions in Parkinsonism C Delaville, J Chetrit, K Abdallah, S Morin, L Cardoit, P De Deurwaerdère, ... Neurobiology of disease 45 (2), 763-773, 2012 | 116 | 2012 |
Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease S Navailles, B Bioulac, C Gross, P De Deurwaerdère Neurobiology of disease 41 (2), 585-590, 2011 | 116 | 2011 |
In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum S Navailles, P De Deurwaerdere, G Porras, U Spampinato Neuropsychopharmacology 29 (2), 319-326, 2004 | 110 | 2004 |